15.80
price down icon8.30%   -1.43
 
loading
Biohaven Ltd stock is traded at $15.80, with a volume of 2.29M. It is down -8.30% in the last 24 hours and up +12.78% over the past month. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
See More
Previous Close:
$17.23
Open:
$17.55
24h Volume:
2.29M
Relative Volume:
1.05
Market Cap:
$1.67B
Revenue:
-
Net Income/Loss:
$-766.97M
P/E Ratio:
-2.0627
EPS:
-7.66
Net Cash Flow:
$-646.43M
1W Performance:
-0.06%
1M Performance:
+12.78%
6M Performance:
-7.76%
1Y Performance:
-69.29%
1-Day Range:
Value
$15.71
$17.61
1-Week Range:
Value
$14.98
$17.61
52-Week Range:
Value
$12.79
$54.98

Biohaven Ltd Stock (BHVN) Company Profile

Name
Name
Biohaven Ltd
Name
Phone
203-404-0410
Name
Address
215 CHURCH STREET, NEW HAVEN, CT
Name
Employee
256
Name
Twitter
@biohavenpharma
Name
Next Earnings Date
2025-08-08
Name
Latest SEC Filings
Name
BHVN's Discussions on Twitter

Compare BHVN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
BHVN
Biohaven Ltd
15.80 1.82B 0 -766.97M -646.43M -7.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-17-25 Initiated Citigroup Buy
Sep-03-25 Initiated Raymond James Strong Buy
May-19-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-11-25 Initiated Deutsche Bank Buy
Sep-16-24 Initiated Jefferies Buy
Sep-04-24 Initiated Bernstein Outperform
Jul-24-24 Initiated Morgan Stanley Overweight
Feb-16-24 Initiated RBC Capital Mkts Outperform
Feb-06-24 Initiated UBS Buy
Dec-22-23 Initiated H.C. Wainwright Buy
Dec-08-23 Initiated Robert W. Baird Outperform
Jan-24-23 Initiated SVB Securities Outperform
Jan-04-23 Initiated JP Morgan Overweight
Dec-02-22 Initiated BTIG Research Buy
Oct-26-22 Upgrade Cantor Fitzgerald Neutral → Overweight
Oct-12-22 Initiated Piper Sandler Overweight
Aug-19-22 Downgrade Piper Sandler Overweight → Neutral
Aug-08-22 Downgrade Wedbush Outperform → Neutral
May-11-22 Downgrade SVB Leerink Outperform → Mkt Perform
Oct-19-21 Resumed Morgan Stanley Equal-Weight
Aug-10-21 Downgrade UBS Buy → Neutral
Aug-03-21 Reiterated Canaccord Genuity Buy
Mar-11-21 Initiated UBS Buy
Dec-15-20 Initiated H.C. Wainwright Buy
Apr-17-20 Initiated Cowen Outperform
Feb-10-20 Downgrade Oppenheimer Outperform → Perform
Feb-06-20 Initiated Mizuho Buy
Nov-22-19 Initiated Wedbush Outperform
Jun-25-19 Reiterated Canaccord Genuity Buy
May-06-19 Initiated Goldman Buy
Apr-09-19 Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-04-19 Reiterated Needham Buy
Jul-03-18 Reiterated Needham Buy
Jul-02-18 Reiterated Needham Buy
Apr-05-18 Downgrade Barclays Overweight → Equal Weight
Feb-22-18 Reiterated Canaccord Genuity Buy
Dec-15-17 Initiated Canaccord Genuity Buy
Oct-03-17 Reiterated Needham Buy
View All

Biohaven Ltd Stock (BHVN) Latest News

pulisher
Oct 12, 2025

Will Biohaven Ltd. stock remain a Wall Street favoriteJuly 2025 Retail & Weekly High Return Opportunities - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Biohaven Ltd. stock chart pattern explainedCPI Data & Free Community Supported Trade Ideas - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Will Biohaven Ltd. stock pay special dividends2025 Retail Activity & Weekly High Momentum Picks - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Will Biohaven Ltd. see short term momentumQuarterly Risk Review & Low Risk High Reward Ideas - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

How to recover losses in Biohaven Ltd. stockQuarterly Market Review & Weekly Return Optimization Plans - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

Biohaven (NYSE:BHVN) Trading 7% HigherStill a Buy? - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reaffirms "Sell (E+)" Rating for Biohaven (NYSE:BHVN) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Pfizer settles Biohaven kickback case with DOJ for $60M - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Leading vs lagging indicators on Biohaven Ltd. performanceWeekly Trade Review & Capital Protection Trading Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Biohaven Ltd. Common Shares stock outperform energy sector in 2025Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Should Biohaven's (BHVN) Accelerating Cash Burn and Shorter Runway Require Action From Investors? - simplywall.st

Oct 07, 2025
pulisher
Oct 07, 2025

New Haven startup Bexorg uses donated brains to reshape drug discovery - Hartford Business Journal

Oct 07, 2025
pulisher
Oct 07, 2025

Biohaven (NYSE:BHVN) Trading Down 4.6%Here's Why - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

A Look at Biohaven (BHVN) Valuation as Cash Runway Narrows and Funding Concerns Grow - simplywall.st

Oct 06, 2025
pulisher
Oct 06, 2025

Biohaven Ltd.’s volatility index tracking explainedQuarterly Portfolio Summary & Fast Moving Stock Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Biohaven Ltd. stock trend forecastIndex Update & Reliable Intraday Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Published on: 2025-10-06 07:41:08 - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 05:51:51 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Biohaven Ltd. Common Shares stock a contrarian opportunityQuarterly Profit Summary & Smart Money Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Biohaven Ltd. recovery potential after sell off2025 Buyback Activity & Reliable Entry Point Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Sentiment analysis tools applied to Biohaven Ltd.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Regression analysis insights on Biohaven Ltd. performanceStop Loss & Short-Term High Return Strategies - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What indicators show strength in Biohaven Ltd.Long Setup & Real-Time Chart Breakout Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is Biohaven Ltd. stock a good choice for value investorsRisk Management & Free Community Consensus Stock Picks - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” - MSN

Oct 01, 2025
pulisher
Sep 29, 2025

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 05:11:50 - newser.com

Sep 29, 2025

Biohaven Ltd Stock (BHVN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Biohaven Ltd Stock (BHVN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Car Bruce
Chief Scientific Officer
Jan 05 '25
Option Exercise
0.00
4,750
0
7,133
Gentile Kimberly
SVP, Clinical Operations
Jan 05 '25
Option Exercise
0.00
3,750
0
99,719
Clark George C.
VP, Chief Accounting Officer
Jan 05 '25
Option Exercise
0.00
2,500
0
66,168
Buten Matthew
Chief Financial Officer
Jan 05 '25
Option Exercise
0.00
4,250
0
196,013
Coric Vlad
Chief Executive Officer
Jan 05 '25
Option Exercise
0.00
14,250
0
1,803,409
CHILDS JOHN W
Director
Dec 30 '24
Buy
35.94
29,000
1,042,393
2,368,741
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Cap:     |  Volume (24h):